SightfileU.S. market data from official filings

Companies › CHRS

COHERUS ONCOLOGY INC (CHRS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001512762 · EDGAR filings · Updated 2026-07-27

COHERUS ONCOLOGY INC (CHRS) has reported institutional ownership of 38.3%, with 156 institutional managers holding positions valued at $99.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
38.3%
Institutional managers
156
Reported 13F value
$99.8M
Insider activity
5 trans.
−$74.0K net selling
Data flags
2 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, COHERUS ONCOLOGY INC has 156 institutional holders and institutional ownership of 38.3%.

Insider activity

Insiders reported 5 transactions (0 buys, 1 sells) across 3 reporting insiders, with a net reported value of −$74.0K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-07-03 (recurring since 2025-07-03) — source filing. The authoritative details are those stated in the filing itself.
Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2024-03-04 (recurring since 2024-03-04) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ELECTROMED INC (ELMD) · SILENCE THERAPEUTICS PLC (SLN) · ZENTALIS PHARMACEUTICALS INC (ZNTL) · FENNEC PHARMACEUTICALS INC (FENC) · Sol-Gel Technologies Ltd (SLGL) · PEPGEN INC (PEPG)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.